Daily Dose - Dec 9th, 2025
Daily Dose |
View online
December 9, 2025
Ardena’s US expansion positions the CDMO for growth amid geopolitical uncertainty
The company earlier this year purchased a Catalent drug product manufacturing facility in Somerset, New Jersey, securing its first footprint in the United States.
Read More
CSL opens $1B cell-based flu vaccine and antivenom manufacturing site in Australia
The new operation replaces CSL Seqirus’ egg-based manufacturing facility and boosts capacity for seasonal and pandemic influenza response.
Read More
Cellular Origins secures $40M to expand robotic cell therapy manufacturing platform
Investment will support the expansion of commercial operations, integration of additional units, and development of manufacturing infrastructure.
Read More